OA22.04 Immune oscillatory nature through menstrual cycle regulation drives SHIV susceptibility from vaginal challengeOral Abstract SessionMicrobiome & STI: impact on prevention
PE19.01 Population-level correlation between incidence of selected sexually transmitted infections and HIV-1 among women participating in HIV pre-exposure prophylaxis trials in AfricaE-posterMicrobiome & STI: impact on prevention
PE19.02 Immunomodulatory properties of cervicovaginal Lactobacillus isolates are associated with lactic acid production and bacterial proteome profilesE-posterMicrobiome & STI: impact on prevention
PE19.03 Lactic acid produced by an optimal vaginal microbiota promotes cervicovaginal epithelial barrier integrity: implications for HIV transmissionE-posterMicrobiome & STI: impact on prevention
PE19.04 Correlates of STI acquisition during the first years after sexual initiation: a longitudinal cohort study of sexually inexperienced adolescent girls and young women in KenyaE-posterMicrobiome & STI: impact on prevention
PE19.05 Cervicovaginal microbiota affects the human ectocervical epithelial barrier as determined by in situ image analysis and protein profilingE-posterMicrobiome & STI: impact on prevention
PE19.06 Female genital tract secretions obtained in the setting of bacterial vaginosis enhance HIV infectionE-posterMicrobiome & STI: impact on prevention
PE19.07 HIV exposure alters the fecal microbiome in Nigerian infantsE-posterMicrobiome & STI: impact on prevention
PE19.08 Gardnerella subgroups exhibit divergent associations with cervicovaginal cytokines in a longitudinal cohort of Kenyan women: Implications for HIV susceptibilityE-posterMicrobiome & STI: impact on prevention
PE19.09LB Experimental microbial dysbiosis enhances rectal SIV acquisition in male rhesus macaquesE-posterMicrobiome & STI: impact on prevention
seek-warrow-warrow-eseek-e111 - 120 of 444 items